Health and Fitness Health and Fitness
Mon, October 25, 2010
Sun, October 24, 2010
[ Sun, Oct 24th 2010 ] - Market Wire
Alcon Board Elects New Chairman
Sat, October 23, 2010
Fri, October 22, 2010
Thu, October 21, 2010
Wed, October 20, 2010
[ Wed, Oct 20th 2010 ] - Market Wire
STJ, AGAM, BAC, MDT, BSX
Tue, October 19, 2010
Mon, October 18, 2010
Sun, October 17, 2010
Sat, October 16, 2010
Fri, October 15, 2010
Thu, October 14, 2010
Wed, October 13, 2010
Tue, October 12, 2010
Mon, October 11, 2010
[ Mon, Oct 11th 2010 ] - Market Wire
SNY,GENZ,LH,AVB,MU
[ Mon, Oct 11th 2010 ] - Market Wire
ARAY,SI,VAR,TOMO,JMBA
Sun, October 10, 2010
Sat, October 9, 2010
Fri, October 8, 2010
Thu, October 7, 2010
[ Thu, Oct 07th 2010 ] - Market Wire
30pm CST
Wed, October 6, 2010
Tue, October 5, 2010
Mon, October 4, 2010
Sun, October 3, 2010
Fri, October 1, 2010

Clinical Data, Inc. to Present at the Newsmakers in the Biotech Industry Conference


//health-fitness.news-articles.net/content/2010/ .. wsmakers-in-the-biotech-industry-conference.html
Published in Health and Fitness on Thursday, October 14th 2010 at 4:35 GMT by Market Wire   Print publication without navigation


NEWTON, Mass.--([ BUSINESS WIRE ])--[ Clinical Data, Inc. ] ([ NASDAQ: CLDA ]), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a Company overview at the BioCentury Newsmakers in the Biotech Industry Conference, October 22, 2010 at the Millennium Broadway Hotel, New York, NY. Clinical Dataa™s presentation will take place at 11:30 a.m. EDT.

A live audio and archived webcast of the Companya™s presentation can be accessed through Clinical Data's website at [ www.clda.com ].

About Clinical Data, Inc.

Clinical Data develops first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for [ central nervous system disorders ] and [ cardiovascular diseases ], to be followed by promising drug candidates in [ other major therapeutic areas ]. Clinical Data combines its drug development and biomarker expertise in an effort to develop products with enhanced efficacy and tolerability to improve patient health and reduce costs. To learn more, please visit the Company's website at [ www.clda.com ].


Publication Contributing Sources